*Five Years Citation in Google scholar (2016 - 2020) is. 1451*   *    IJPR IS INDEXED IN ELSEVIER EMBASE & EBSCO *       

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence
Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
No Data found.
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Comparing the efficacy of Olopatadine Hydrochloride and Alcaftadine in the treatment of Allergic Conjunctivitis

Author: B.SANDHYA, TEENA ROSE.D.C, UDIT SAGAR
Abstract: Aim: The study’s goals were to (1) To assess which of the two drugs (alcaftadine, olopatadine HCL) alleviates the symptoms better and faster in patients with allergic conjunctivitis that is mild to moderate in nature. (2) To assess the common drug-related adverse effects. Methodology: Our research was a Prospective, Open Label, Randomized study that took place in the Ophthalmology (OPD) department of MVJ Medical College and Research Hospital for a time period of 6 months after approval from the Institutional Ethical Committee. There were several inclusion standards that divided the participants into 2 groups Group 1 – Participants administering Olopatadine Hydrochloride Group 2 – Participants administering Alcaftadine The basic demographics, chief complaints and Total ocular symptom scores (used for comparing the efficacy) were recorded using ‘Patient Pro forma’. Results: The study included 138 participants in total. Utilizing the Wilcoxon rank-sum test in Statistical Analysis Software version 9.2, the mean scores, standard deviation, and p values from the baseline (Day 1), Day 3, and Day 7 were calculated. The p-value on day 1 was determined to be 0.45, while the p-value on day 3 was 0.43. The outcomes on these days showed that neither of the patient's group’s responses was statistically significant. The p-value on Day 7 was considered statistically significant, with the value being 0.016. The common adverse effects of the drugs were found to be a burning sensation, headache, dizziness, and redness. Conclusion: Both medications were found out to be effective in treating allergic conjunctivitis, with Alcaftadine being significantly more efficacious than Olopatadine in terms of treating the allergic symptoms.
Keyword: Alcaftadine, olopatadine, efficacy, Total ocular symptom score (TOSS), allergic conjunctivitis
DOI: https://doi.org/10.31838/ijpr/2024.16.01.011
Download: Request For Article
 
Clients

Clients

Clients

Clients

Clients
ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free